CAS 869185-85-3

SB 203580 hydrochloride

CAS : 869185-85-3

SB 203580 hydrochloride

Degré de pureté : ≥95%

Masse moléculaire : 413.9g/mol

Ref: 54-BUP10732

SB-203580 Hydrochloride

CAS : 869185-85-3

SB-203580 Hydrochloride

Masse moléculaire : 413.90g/mol

Ref: 54-BISN0245

SB 203580 hydrochloride

CAS : 869185-85-3

SB 203580 hydrochloride (Adezmapimod hydrochloride) is a p38 MAPK inhibitor that induces mitochondrial autophagy and cytosolic autophagy.

Formule : C₂₁H₁₇ClFN₃OS

Degré de pureté : 97.79%

Couleur et forme : Solid

Masse moléculaire : 413.9

Ref: TM-T21675

SB 203580 Hydrochloride

Produit contrôlé

CAS : 869185-85-3

Formule : C₂₁H₁₆FN₃OS·HCl

Couleur et forme : Neat

Masse moléculaire : 377.43 + 36.46

Ref: TR-S155058

SB 203580 hydrochloride

CAS : 869185-85-3

SB 203580 hydrochloride is a p38 MAPK inhibitor that binds to the receptor site of the human serum albumin. It has been shown to have a significant effect on cell proliferation and cell migration in corneal endothelial cells and epidermal growth factor receptor-positive epithelial cells in culture. SB 203580 hydrochloride also inhibits protease activity, which may be related to its ability to inhibit tumor necrosis factor-α (TNF-α) production. SB 203580 hydrochloride is a nanoparticulate composition that can be used for treatment of inflammatory disorders such as asthma, COPD, and rheumatoid arthritis.

Formule : C₂₁H₁₆FN₃OS·HCl

Degré de pureté : Min. 95%

Masse moléculaire : 413.89 g/mol

Ref: 3D-UJB18585